The chemotherapy regimen for acute monocytic leukaemia consists of two phases: induction therapy and consolidation therapy. 3+7 regimen is generally preferred for induction therapy, i.e. a regimen of 3 days of anthracyclines (desoxorubicin or erythromycin) combined with 7 days of cytarabine drugs. After the standard dose of induction chemotherapy, consolidation therapy can be considered, and for patients with a good prognosis, 4 courses of consolidation with medium dose cytarabine can be used . It is important to note that there are individual differences in chemotherapy dosing and should be strictly adhered to as prescribed by the doctor and not used indiscriminately.